| Title: | Prevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty |
| Journal: | The Journal of Clinical Endocrinology & Metabolism |
| Published: | 20 Jun 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37339320/ |
| DOI: | https://doi.org/10.1210/clinem/dgad373 |
| URL: | https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad373/50660988/dgad373.pdf |
| Citations: | 5 (5 in last 2 years) as of 8 Aug 2024 |
Publication 11578
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
CONTEXT: The melanocortin 3 receptor (MC3R) has recently emerged as a critical regulator of pubertal timing, linear growth, and the acquisition of lean mass in humans and mice. In population-based studies, heterozygous carriers of deleterious variants in MC3R report a later onset of puberty than noncarriers. However, the frequency of such variants in patients who present with clinical disorders of pubertal development is currently unknown.</p>
OBJECTIVE: This work aimed to determine whether deleterious MC3R variants are more frequently found in patients clinically presenting with constitutional delay of growth and puberty (CDGP) or normosmic idiopathic hypogonadotropic hypogonadism (nIHH).</p>
METHODS: We examined the sequence of MC3R in 362 adolescents with a clinical diagnosis of CDGP and 657 patients with nIHH, experimentally characterized the signaling properties of all nonsynonymous variants found and compared their frequency to that in 5774 controls from a population-based cohort. Additionally, we established the relative frequency of predicted deleterious variants in individuals with self-reported delayed vs normally timed menarche/voice-breaking in the UK Biobank cohort.</p>
RESULTS: MC3R loss-of-function variants were infrequent but overrepresented in patients with CDGP (8/362 [2.2%]; OR = 4.17; P = .001). There was no strong evidence of overrepresentation in patients with nIHH (4/657 [0.6%]; OR = 1.15; P = .779). In 246 328 women from the UK Biobank, predicted deleterious variants were more frequently found in those self-reporting delayed (aged ≥16 years) vs normal age at menarche (OR = 1.66; P = 3.90E-07).</p>
CONCLUSION: We have found evidence that functionally damaging variants in MC3R are overrepresented in individuals with CDGP but are not a common cause of this phenotype.</p>
36 Authors
- Katie Duckett
- Alice Williamson
- John W R Kincaid
- Kara Rainbow
- Laura J Corbin
- Hilary C Martin
- Ruth Y Eberhardt
- Qin Qin Huang
- Matthew E Hurles
- Wen He
- Raja Brauner
- Angela Delaney
- Leo Dunkel
- Romina P Grinspon
- Janet E Hall
- Joel N Hirschhorn
- Sasha R Howard
- Ana C Latronico
- Alexander A L Jorge
- Ken McElreavey
- Verónica Mericq
- Paulina M Merino
- Mark R Palmert
- Lacey Plummer
- Rodolfo A Rey
- Raíssa C Rezende
- Stephanie B Seminara
- Kathryn Salnikov
- Indraneel Banerjee
- Brian Y H Lam
- John R B Perry
- Nicholas J Timpson
- Peter Clayton
- Yee-Ming Chan
- Ken K Ong
- Stephen O'Rahilly
1 Application
| Application ID | Title |
|---|---|
| 9905 | Using genetics to elucidate the relationship between socioeconomic/behavioural traits and disease |
Enabling scientific discoveries that improve human health